IL1B and arthritic joint disease: W. Qi et al. reported that SIN exhibited anti-arthritis biopotency, inhibiting MMP production by increasing SOCS3 and impeding IL-1β-induced TRAF6–TAK1 interaction and IL-6-induced JAK2 and STAT3 phosphorylation [119].